Skip to main content
ConductScienceScienceDex

Juan Enrique Rozengurt

NIH Rank #6857
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6774619Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2024

Linked Award Amount
$1.7M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#6,857
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Juan Enrique Rozengurt. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Juan Enrique Rozengurt as a PI. Multi-PI records show the full award amount for context.

  • 2R01AI135201-06R01
    The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection
    University of California, Los Angeles
    $747.6K
    award amount
  • 5R01AI173050-02R01
    Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
    University of California, Los Angeles
    $710.7K
    award amount
  • 5P01CA236585-05P01
    Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
    University of California, Los Angeles
    $280.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Juan Enrique Rozengurt as a PI.

FY2024 award administered by University of California, Los Angeles (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6857
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Juan Enrique Rozengurt.

Elaine F Reed
University of California, Los Angeles
6
shared awards
Robert L Fairchild
University of California, Los Angeles
6
shared awards
Guido Erwin Michael Eibl
University of California, Los Angeles
1
shared award
Stephen J. Pandol
University of California, Los Angeles
1
shared award
Vay Liang W Go
University of California, Los Angeles
1
shared award

Explore further

Find collaborators for Juan Enrique Rozengurt

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →